Urocid-N Oral Solution

Citric Acid Monohydrate 5% + Potassium Citrate 30%

5 gm + 30 gm/100 ml

One Pharma Ltd.

Pack size	200 ml
Unite Price	200.00 BDT

Indications

Urocid-N Oral Solution is used for: Prevention of gout and kidney stones, Urine alkalinization, Renal tubular acidosis

Adult Dose

Urinary Alkalinization Indicated for long-term maintenance of an alkaline urine (eg, patients with uric acid and cystine calculi of the urinary tract), especially when the administration of sodium salts is undesirable or contraindicated Usual dose: 15-30 mL PO diluted with 1 glass of water QID (after meals and at bedtime)

Child Dose

Urinary Alkalinization Indicated for long-term maintenance of an alkaline urine (eg, patients with uric acid and cystine calculi of the urinary tract), especially when the administration of sodium salts is undesirable or contraindicated Usual dose: 5-15 mL PO diluted with one-half glass of water QID (after meals and at bedtime)

Renal Dose

Administration

Dilute oral solution in water according to directions, followed by additional water, if desired Proper dilution may help prevent gastrointestinal injury associated with the oral ingestion of concentrated potassium salt preparations Palatability enhanced if chilled

Contra Indications

The drug is contraindicated in severe renal impairment with oliguria or azotemia, untreated Addison's disease, acute dehydration, severe myocardial damage, and hyperkalemia from any cause.

Precautions

The solution should be used with caution in patients with low urinary output. It should be diluted adequately with water to minimize the possibility of gastrointestinal injury associated with the oral ingestion of concentrated potassium salt preparations; and preferably, to take each dose after meals. Large doses may cause hyperkalemia and alkalosis, especially in the presence of renal disease. Lactation: Unknown whether distributed in breast milk

Pregnancy-Lactation

Interactions

Side Effects

Side effects of Citric Acid Monohydrate 5% + Potassium Citrate 30% : This solution is generally well tolerated without any unpleasant side effect when given in recommended doses to patients with normal renal function and urinary output. However, as with any alkalinizing agent, caution must be used in certain patients with abnormal renal mechanisms to avoid development of hyperkalemia or alkalosis. Potassium intoxication causes listlessness, weakness, mental confusion, tingling of extremities, and other symptoms associated with a high concentration of potassium in the serum.

Mode of Action

Potassium citrate is absorbed and metabolized to potassium bicarbonate and this acts as a systemic alkalizer .

Note

Urocid-N 5 gm + 30 gm/100 ml Oral Solution generic name is Citric Acid Monohydrate 5% + Potassium Citrate 30%. Urocid-N 5 gm + 30 gm/100 ml Oral Solution is manufactured by One Pharma Ltd.Urocid-N is availble in all over Bangladesh. Mes BD drug index information on Urocid-N Oral Solution is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Citric Acid Monohydrate 5% + Potassium Citrate 30% :

Oral Solution

Urikal ^{5 gm + 30 gm/100 ml}

Incepta Pharmaceuticals Ltd.

Oral Solution

Urinor ^{(1500 mg+250 mg)/5 ml}

Novelta Bestway Pharmaceuticals Ltd.

Syrup

Citra-K ^{5 gm + 30 gm/100 ml}

Unimed & Unihealth Manufacturers Ltd.

Oral Solution

Urokit Plus ^{5gm + 30gm/5ml}

Eskayef Pharmaceuticals Ltd.

Oral Solution

Uriset ^{(1500 mg + 250 mg)/5 ml}

Square Pharmaceuticals Ltd.